Oncogene - Table of Contents alert Volume 36 Issue 9

If you are unable to see the message below, click here to view.

Advertisement Specific CRISPR/Cas9/Cpf1 antibodies for clean and reliable results Validated for chromatin immunoprecipiation, IP, IF, Western blots Available from S. pyogenes and S. aureus raised against the N- or C-terminus Polyclonal and monoclonal  Learn more about our large collection of verified Cas9 and Cpf1 antibodies  TABLE OF CONTENTS Volume 36, Issue 9 (March 2017) In this issue Reviews Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Reviews Top Hotspots of MLV integration in the hematopoietic tumor genome OPEN T Tsuruyama, T Hiratsuka and N Yamada Oncogene 2017 36: 1169-1175; advance online publication, November 7, 2016; 10.1038/onc.2016.285 Abstract | Full Text The role of claudins in cancer metastasis S Tabariès and P M Siegel Oncogene 2017 36: 1176-1190; advance online publication, August 15, 2016; 10.1038/onc.2016.289 Abstract | Full Text Original Articles Top The novel G-quadruplex-containing long non-coding RNA GSEC antagonizes DHX36 and modulates colon cancer cell migration K Matsumura, Y Kawasaki, M Miyamoto, Y Kamoshida, J Nakamura, L Negishi, S Suda and T Akiyama Oncogene 2017 36: 1191-1199; advance online publication, October 31, 2016; 10.1038/onc.2016.282 Abstract | Full Text Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort M Apicella, C Migliore, T Capelôa, S Menegon, M Cargnelutti, M Degiuli, A Sapino, A Sottile, I Sarotto, L Casorzo, P Cassoni, M De Simone, P M Comoglio, S Marsoni, S Corso and S Giordano Oncogene 2017 36: 1200-1210; advance online publication, August 15, 2016; 10.1038/onc.2016.283 Abstract | Full Text CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients OPEN S Lefort, A Thuleau, Y Kieffer, P Sirven, I Bieche, E Marangoni, A Vincent-Salomon and F Mechta-Grigoriou Oncogene 2017 36: 1211-1222; advance online publication, September 26, 2016; 10.1038/onc.2016.284 Abstract | Full Text Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth OPEN X Deng, G Shao, H-T Zhang, C Li, D Zhang, L Cheng, B D Elzey, R Pili, T L Ratliff, J Huang and C-D Hu Oncogene 2017 36: 1223-1231; advance online publication, August 22, 2016; 10.1038/onc.2016.287 Abstract | Full Text Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma S Murakami, D Shahbazian, R Surana, W Zhang, H Chen, G T Graham, S M White, L M Weiner and C Yi Oncogene 2017 36: 1232-1244; advance online publication, August 22, 2016; 10.1038/onc.2016.288 Abstract | Full Text LKB1 inhibits HPV-associated cancer progression by targeting cellular metabolism Q Zeng, J Chen, Y Li, K D Werle, R-X Zhao, C-S Quan, Y-S Wang, Y-X Zhai, J-W Wang, M Youssef, R Cui, J Liang, N Genovese, L T Chow, Y-L Li and Z-X Xu Oncogene 2017 36: 1245-1255; advance online publication, August 22, 2016; 10.1038/onc.2016.290 Abstract | Full Text The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms OPEN Y-X Jiang, S-W Yang, P-A Li, X Luo, Z-Y Li, Y-X Hao and P-W Yu Oncogene 2017 36: 1256-1264; advance online publication, August 15, 2016; 10.1038/onc.2016.291 Abstract | Full Text Aurora A kinase activates YAP signaling in triple-negative breast cancer S-S Chang, H Yamaguchi, W Xia, S-O Lim, Y Khotskaya, Y Wu, W-C Chang, Q Liu and M-C Hung Oncogene 2017 36: 1265-1275; advance online publication, September 5, 2016; 10.1038/onc.2016.292 Abstract | Full Text Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells OPEN K Tominaga, T Shimamura, N Kimura, T Murayama, D Matsubara, H Kanauchi, A Niida, S Shimizu, K Nishioka, E-i Tsuji, M Yano, S Sugano, Y Shimono, H Ishii, H Saya, M Mori, K Akashi, K-i Tada, T Ogawa, A Tojo, S Miyano and N Gotoh Oncogene 2017 36: 1276-1286; advance online publication, August 22, 2016; 10.1038/onc.2016.293 Abstract | Full Text Sensitization of retinoids and corticoids to epigenetic drugs in MYC-activated lung cancers by antitumor reprogramming O A Romero, S Verdura, M Torres-Diz, A Gomez, S Moran, E Condom, M Esteller, A Villanueva and M Sanchez-Cespedes Oncogene 2017 36: 1287-1296; advance online publication, September 5, 2016; 10.1038/onc.2016.296 Abstract | Full Text RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways L Zhang, P Wang, Y Qin, Q Cong, C Shao, Z Du, X Ni, P Li and K Ding Oncogene 2017 36: 1297-1308; advance online publication, September 12, 2016; 10.1038/onc.2016.306 Abstract | Full Text Short Communication Top Sustained p16INK4a expression is required to prevent IR-induced tumorigenesis in mice L Palacio, V Krishnan, N L O Le, N E Sharpless and C M Beauséjour Oncogene 2017 36: 1309-1314; advance online publication, August 29, 2016; 10.1038/onc.2016.298 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.